Nine research projects at Rice University have been granted $25,000 to advance their innovative solutions. Photo courtesy of Rice

Over a dozen Houston researchers wrapped up 2021 with the news of fresh funding thanks to an initiative and investment fund from Rice University.

The Technology Development Fund is a part of the university’s Creative Ventures initiative, which has awarded more than $4 million in grants since its inception in 2016. Rice's Office of Technology Transfer orchestrated the $25,000 grants across nine projects. Submissions were accepted through October and the winners were announced a few weeks ago.

The 2021 winners, according to Rice's news release, were:

  • Kevin McHugh, an assistant professor of bioengineering, is working on a method to automate an encapsulation process that uses biodegradable microparticles in the timed release of drugs to treat cancer and prevent infectious disease. He suggested the process could help ramp up the manufacture of accessible multidose vaccines.
  • Daniel Preston, an assistant professor of mechanical engineering, is developing a novel filtration system that will recover water typically released by cooling towers at natural gas power plants. The inexpensive filters will result in a significant savings in water costs during power generation.
  • Geoff Wehmeyer, an assistant professor of mechanical engineering; Matteo Pasquali, the A.J. Hartsook Professor of Chemical and Biomolecular Engineering and a professor of chemistry and materials science and nanoengineering; Junichiro Kono, the Karl F. Hasselmann Chair in Engineering, a professor of electrical and computer engineering, physics and astronomy and materials science and nanoengineering and chair of the applied physics program, and Glen Irvin Jr., a research professor in chemical and biomolecular engineering, are creating a solid-state, active heat-switching device to enable the rapid charging of batteries for electric vehicles. The lightweight device will use carbon nanotube fibers to optimize battery thermal management systems not only for cars but also, eventually, for electronic devices like laptops.
  • Xia Ben Hu, an associate professor of computer science, is developing his open-source machine learning system to democratize and accelerate small businesses’ digital transformation in e-commerce.
  • Bruce Weisman, a professor of chemistry and of materials science and nanoengineering, and Satish Nagarajaiah, a professor of civil and environmental engineering and of mechanical engineering, are working to advance their strain measurement system based on the spectral properties of carbon nanotubes. The system will allow for quick measurement of strain to prevent catastrophic failures and ensure the safety of aircraft, bridges, buildings, pipelines, ships, chemical storage vessels and other infrastructure.
  • Aditya Mohite, a professor of chemical and biomolecular engineering and associate professor of materials science and nanoengineering, and Michael Wong, the Tina and Sunit Patel Professor in Molecular Nanotechnology, a professor and chair of chemical and biomolecular engineering and a professor of chemistry, materials science and nanoengineering and of civil and environmental engineering, are scaling up novel photoreactors for the environmentally friendly generation of hydrogen. Their process combines of perovskite-based solar cells and state-of-the-art catalysts.
  • Rebekah Drezek, a professor of bioengineering, and Richard Baraniuk, the C. Sidney Burrus Professor of Electrical and Computer Engineering and a professor of statistics and computer science, are developing a system to rapidly diagnose sepsis using microfluidics and compressed sensing to speed the capture and analysis of microbial biomarkers.
  • Fathi Ghorbel, a professor of mechanical engineering and of bioengineering, is working on robotic localization technology in GPS-denied environments such as aboveground storage tanks, pressure vessels and floating production storage and offloading tanks. The system would enable robots to precisely associate inspection data to specific locations leading to efficiency and high quality of inspection and maintenance operations where regular inspections are required. This will dramatically improve the environmental impact and safety of these assets.
  • Kai Fu, a research scientist, and Yuji Zhao, an associate professor of electrical and computer engineering, are working to commercialize novel power diodes and transistors for electric vehicles. They expect their devices to reduce the volume of power systems while improving integration, power density, heat dissipation, storage, and energy efficiency.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

Axiom Space tops $525M in oversubscribed round, announces Swiss subsidiary

funding boost

Axiom Space tacked on an additional $175 million to a previously announced capital raise, bringing the oversubscribed round to a total of more than $525 million.

Axiom shared in February that it had secured $350 million in a financing round led by Type One Ventures and Qatar Investment Authority. In the latest release from the company, Axiom reports that Japan-based MUFG Bank Ltd. joined the round as a new investor, in addition to continued participation from existing backers.

The funding will go toward developing the company's commercial space station, known as Axiom Station, and the production of its Axiom Extravehicular Mobility Unit (AxEMU) under its NASA spacesuit contract.

“Investor interest in this round outpaced what we set out to raise, which speaks to the moment we’re in,” Jonathan Cirtain, CEO and president of Axiom Space, said in the news release. “Our partners see what is possible in low-Earth orbit, and they see who is positioned to lead it.”

Axiom announced last month that it planned to open a Japanese subsidiary July 1. Earlier this week, it also shared plans to establish Axiom Space Switzerland, a wholly owned subsidiary based in Lucerne that is also expected to begin operations this summer.

The Switzerland subsidiary aims to establish Axiom's presence in Europe and help it partner with the European Space Agency and other space organizations and companies on the continent.

“Europe is a founding leader in the creation of the commercial space economy, and Switzerland is uniquely positioned to convene the government agencies, research institutions, and industrial entities that will shape its next decade,” Cirtain added in a separate release. “Axiom Space Switzerland facilitates the scaling of development and deployment of the infrastructure that will succeed the International Space Station.”

Texas cashes in among 10 best U.S. state economies in 2026 report

State Economics

A new study gauging the success or decline in economic performance in every state has revealed Texas' economy remains stable in 2026 after it dropped out of the top five to No. 8 last year.

Texas boasts the No. 8 best state economy in the U.S. this year, according to WalletHub's annual "Best & Worst State Economies" report. The personal finance website's analysts ranked all 50 states and the District of Columbia across 28 relevant metrics to measure each state's economic activity and health status, and its "innovation potential."

Notably, Texas leads the nation for the most exports per capita in the U.S. in a five-way tie with Louisiana, Kentucky, North Dakota, and Indiana. Across the study's three main categories, Texas ranked highly for its economic activity (No. 7) and economic health (No. 11), and the state's "innovation potential" rank is the 24th best in the nation.

This is how WalletHub ranked Texas' economic performance, where No. 1 is considered the best and No. 25 is considered average:
  • No. 6 – Change in non-farm payrolls
  • No. 8 – Change in GDP
  • No. 8 – Startup activity
  • No. 11 – Annual median household income
  • No. 18 – Government surplus/deficit per capita
  • No. 21 – Percentage of jobs in high-tech industries
  • No. 30 – Unemployment rate
WalletHub previously ranked Texas one of the top three states to start a business in 2026, with Houston earning its own entrepreneurial acclaim in separate rankings of the best big cities for new businesses and for starting a career.

"U.S. economic growth depends heavily on the performance of individual states, and some contribute more than others," the report's author wrote. "For example, California, Texas, New York and Florida have economies so large that if they were countries, they would rank in the top 20 in the world."

The five states with the worst state economies in 2026 are Rhode Island (No. 47), Maine (No. 48), Louisana (No. 49), Kentucky (No. 50), and West Virginia (No. 51).

The top 10 best state economies for 2026 are:

  • No. 1 – Massachusetts
  • No. 2 – Washington
  • No. 3 – Utah
  • No. 4 – California
  • No. 5 – Delaware
  • No. 6 – North Carolina
  • No. 7 – New York
  • No. 8 – Texas
  • No. 9 – Colorado
  • No. 10 – Florida

---

This article originally appeared on CultureMap.com.